CONFIRMED

This week's evidence shows that assessment and identification at first contact, not treatment availability, determines whether frail, cognitively impaired and dying patients reach the right pathway, while national data confirms the capacity cost of getting it wrong.

A nationwide Finnish cohort found specialist palliative referral more than thirty days before death reduced final-month acute hospitalisation from 38% to 21% and increased hospital-at-home use from 4% to 40%, replicating an NHS heart failure study.

NHS England frailty pathway standards, two convergent palliative trials, AHP timing evidence, and antimicrobial risk data all named the same mechanism across a single week: specialist clinical input that reaches patients earlier produces better outcomes, lower cost, and safer transitions.